Long Term Effects of an Early Response to Certolizumab Pegol (CZP, Cimzia®) in Rheumatoid Arthritis (RA) Patients

NCT01288287 · clinicaltrials.gov ↗
COMPLETED
Status
149
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

UCB Pharma